Treatment-associated toxicities reported by patients with early-stage invasive breast cancer

Author:

Friese Christopher R.12ORCID,Harrison Jordan M.1,Janz Nancy K.3,Jagsi Reshma4,Morrow Monica5,Li Yun6,Hamilton Ann S.7,Ward Kevin C.8,Kurian Allison W.910,Katz Steven J.1112,Hofer Timothy P.1113

Affiliation:

1. Department of Systems; Populations, and Leadership, School of Nursing, University of Michigan; Ann Arbor Michigan

2. Institute for Healthcare Policy and Innovation; University of Michigan; Ann Arbor Michigan

3. Department of Health Behavior and Health Education; School of Public Health, University of Michigan; Ann Arbor Michigan

4. Department of Radiation Oncology; University of Michigan School of Medicine; Ann Arbor Michigan

5. Breast Surgical Service; Memorial Sloan Kettering Cancer Center; New York New York

6. Department of Biostatistics; University of Michigan School of Public Health; Ann Arbor Michigan

7. Department of Preventive Medicine; University of Southern California Keck School of Medicine; Los Angeles California

8. Rollins School of Public Health; Emory University; Atlanta Georgia

9. Department of Medicine; Stanford University Medical Center; Stanford California

10. Department of Health Research and Policy; Stanford University Medical Center; Stanford California

11. Department of Internal Medicine; School of Medicine, University of Michigan; Ann Arbor Michigan

12. Department of Health Management and Policy; School of Public Health, University of Michigan; Ann Arbor Michigan

13. Veterans Affairs Center for Clinical Management Research; Health Services Research and Development Service Center of Innovation, University of Michigan; Ann Arbor Michigan

Funder

National Cancer Institute (NCI)

California Department of Public Health pursuant to California Health and Safety Code Section

Centers for Disease Control and Prevention (CDC)'s National Program of Cancer Registries

NCI's Surveillance, Epidemiology

Cancer Prevention Institute of California

University of Southern California

Public Health Institute

Publisher

Wiley

Subject

Cancer Research,Oncology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3